MENU
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PDF file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

FEB 24, 2021

Drug Discovery & Development 2021



LabRoots and the Drug Discovery planning committee are pleased to announce the 4th Annual Drug Discovery & Development Virtual Conference. LabRoots will host this online-only event on February 24, 2021. The Drug Discovery planning committee will carefully plan and select speakers that best represent the key challenges, opportunities, and issues in the current landscape. These industry leaders will discuss the advancements, challenges and successes of discovery and develop new medications and therapies.

This year's tracks include:
  • New Practices in Early Phase Drug Discovery
  • Novel Advancements to Clinical Development
    • Health Equality and Genetic Diversity in Clinical Trials
  • Modern Approaches to Discovery, Preclinical, and Clinical Lab Operations in the COVID-19 Age
  • Innovative Biomarkers in Drug Development

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.

Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.


Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRdrug to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
FEB 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
FEB 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 11th Annual Laboratory Animal Science Virtual Conference which will take place on February 10, 2022 . This is a premier online-only conference that will b...
Agenda
  • Novel Solutions for High Throughput Antibody and Protein Purification Using Magnetic Beads Platform
    FEB 24, 2021 4:30 PM PST
    Nishant Saxena, PhD
    Product Manager, GenScript
    Sponsored By: GenScript
  • PROTACs: A Chemistry Journey of Protein Degraders
    FEB 24, 2021 3:00 PM PST
    Jie Jack Li, PhD
    Vice President, Discovery Chemistry at ChemPartner
    Sponsored By: ChemPartner
  • FEB 24, 2021 3:00 PM PST
    Leif Schauser, PhD, Joseph Pearson, PhD
    Sponsored By: QIAGEN
    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    Joseph Pearson, PhD
    Global Product Manger
  • FEB 24, 2021 3:00 PM PST
    Leif Schauser, PhD, Joseph Pearson, PhD
    Sponsored By: QIAGEN
    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    Joseph Pearson, PhD
    Global Product Manger
  • FEB 24, 2021 1:30 PM PST
    Annette Gilchrist, PhD, Professor Kevin Pfleger, Juan José Fung, PhD, Aarti Kawatkar, Yamina A. Berchiche, PhD, Ajay Yekkirala, PhD
    Annette Gilchrist, PhD
    Associate-Professor, Pharmaceutical Sciences, Midwester...
    Professor Kevin Pfleger
    Director Biomedical Innovation, The University of Weste...
    Juan José Fung, PhD
    Principal Scientist, GPCR Therapeutics
    Aarti Kawatkar
    Sr. Scientist, Chemical Biology and Proteomics group, A...
    Yamina A. Berchiche, PhD
    Founder, Dr. GPCR
    Ajay Yekkirala, PhD
    Co-Founder & CSO, Blue Therapeutics
  • FEB 24, 2021 12:00 PM PST
    Jason Frazier, Sarah Warren, PhD
    Sponsored By: NanoString Technologies
    Jason Frazier
    Director of Scientific Operations, Presage Biosciences
    Sarah Warren, PhD
    Sr Director of Translational Science, NanoString Techno...
  • Speed up your drug discovery with ready-to-use stable cell lines
    FEB 24, 2021 12:00 PM PST
    Vevian Zhang
    Product Manager, GenScript
    Sponsored By: GenScript
  • FEB 24, 2021 10:30 AM PST
    Sherry A. Dunbar, PhD, MBA, Josh Jenkins, MS
    Sponsored By: LUMINEX
    Sherry A. Dunbar, PhD, MBA
    Senior Director, Global Scientific Affairs
    Josh Jenkins, MS
    Sales Development Manager, Licensed Technologies Group,...
  • FEB 24, 2021 10:30 AM PST
    Keith Bowers, PhD, Dave Mason, PhD
    Sponsored By: Visiopharm®
    Keith Bowers, PhD
    Senior Business Development Manager, OracleBio
    Dave Mason, PhD
    Technical Sales Specialist, Visiopharm
  • FEB 24, 2021 9:00 AM PST
    Andrew Roche, PhD, Roger Hayes, PhD
    Andrew Roche, PhD
    Senior Director, Scientific Affairs, ICON Laboratory Se...
    Roger Hayes, PhD
    Vice President, Bioanalytical Services, ICON Laboratory...
  • Keynote Presentation: The biomarker to companion diagnostic continuum: a road map for the delivery of precision medicine
    FEB 24, 2021 7:30 AM PST
    Steven M. Anderson, PhD
    Chief Scientific Officer, Covance Drug Development
  • Fueling Discovery: Next-generation isolation of PBMCs and primary cells from Miltenyi Biotec
    FEB 24, 2021 6:00 AM PST
    Josh Mahlios, PhD
    Senior Marketing Product Manager, Miltenyi Biotec
    Sponsored By: Miltenyi Biotec
  • Introducing GenScript's DNA-Encoded Chemical Library Kit - GenDECL
    FEB 24, 2021 6:00 AM PST
    Rouba Najjar, MBA
    Senior Product Manager, GenScript
    Sponsored By: GenScript
  • COVID's Impact on Life Sciences Recruiting
    Don Alexander, CPC, CFP®
    President and Managing Director, GeneCoda
  • Evolution of a Platform-Based Non-Clinical Safety Assessment Approach for Vaccines
    Joseph J. Senn, PhD, DABT
    Vice President, Nonclinical Sciences, Moderna
  • Dr. Christian Klose
    CTO, Lipotype GmbH
  • Multi-diagnostic approaches for patient selection in immuno-oncology
    Cindy Spittle
    VP Scientific Affairs, ICON Laboratory Services
  • Nonclinical COVID-19 Vaccine Development During a Pandemic
    Cynthia Rohde, PhD, DABT
    Associate Research Fellow, Drug Safety Research and Development, Pfizer, Inc.
  • Preclinical evaluation of novel OT-analogs for the potential treatment of social behavioral deficits
    Marsha Pierce, PhD
    Assistant Professor, Department of Pharmacology, Midwestern University
  • The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications for Drug Discovery and Development
    Mark Kiel, MD, PhD
    Co-Founder and Chief Science Officer, Genomenon
  • The development and application of TRUPATH biosensors to the study of GPCR pharmacology and functional selectivity
    Reid Olsen, PhD, Pharmacology, Head of GPCR Pharmacology
    Exscientia Ltd
  • Modern Approaches to Discovery, Preclinical and Clinical Lab Operations in COVID-19 Age
  • COVID's Impact on Life Sciences Recruiting
    Don Alexander, CPC, CFP®
    President and Managing Director, GeneCoda
  • New Practices in Early Phase Drug Discovery
  • Preclinical evaluation of novel OT-analogs for the potential treatment of social behavioral deficits
    Marsha Pierce, PhD
    Assistant Professor, Department of Pharmacology, Midwestern University
  • The development and application of TRUPATH biosensors to the study of GPCR pharmacology and functional selectivity
    Reid Olsen, PhD, Pharmacology, Head of GPCR Pharmacology
    Exscientia Ltd
  • FEB 24, 2021 10:30 AM PST
    Keith Bowers, PhD, Dave Mason, PhD
    Sponsored By: Visiopharm®
    Keith Bowers, PhD
    Senior Business Development Manager, OracleBio
    Dave Mason, PhD
    Technical Sales Specialist, Visiopharm
  • FEB 24, 2021 12:00 PM PST
    Jason Frazier, Sarah Warren, PhD
    Sponsored By: NanoString Technologies
    Jason Frazier
    Director of Scientific Operations, Presage Biosciences
    Sarah Warren, PhD
    Sr Director of Translational Science, NanoString Techno...
  • Speed up your drug discovery with ready-to-use stable cell lines
    FEB 24, 2021 12:00 PM PST
    Vevian Zhang
    Product Manager, GenScript
    Sponsored By: GenScript
  • FEB 24, 2021 1:30 PM PST
    Annette Gilchrist, PhD, Professor Kevin Pfleger, Juan José Fung, PhD, Aarti Kawatkar, Yamina A. Berchiche, PhD, Ajay Yekkirala, PhD
    Annette Gilchrist, PhD
    Associate-Professor, Pharmaceutical Sciences, Midwester...
    Professor Kevin Pfleger
    Director Biomedical Innovation, The University of Weste...
    Juan José Fung, PhD
    Principal Scientist, GPCR Therapeutics
    Aarti Kawatkar
    Sr. Scientist, Chemical Biology and Proteomics group, A...
    Yamina A. Berchiche, PhD
    Founder, Dr. GPCR
    Ajay Yekkirala, PhD
    Co-Founder & CSO, Blue Therapeutics
  • PROTACs: A Chemistry Journey of Protein Degraders
    FEB 24, 2021 3:00 PM PST
    Jie Jack Li, PhD
    Vice President, Discovery Chemistry at ChemPartner
    Sponsored By: ChemPartner
  • Novel Advancements to Clinical Development
  • The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications for Drug Discovery and Development
    Mark Kiel, MD, PhD
    Co-Founder and Chief Science Officer, Genomenon
  • Evolution of a Platform-Based Non-Clinical Safety Assessment Approach for Vaccines
    Joseph J. Senn, PhD, DABT
    Vice President, Nonclinical Sciences, Moderna
  • Fueling Discovery: Next-generation isolation of PBMCs and primary cells from Miltenyi Biotec
    FEB 24, 2021 6:00 AM PST
    Josh Mahlios, PhD
    Senior Marketing Product Manager, Miltenyi Biotec
    Sponsored By: Miltenyi Biotec
  • (3) Modern Approaches to Discovery, Preclinical, and Clinical Lab Operations in the COVID-19 Age
  • Nonclinical COVID-19 Vaccine Development During a Pandemic
    Cynthia Rohde, PhD, DABT
    Associate Research Fellow, Drug Safety Research and Development, Pfizer, Inc.
  • Innovative Biomarkers in Drug Development
  • Dr. Christian Klose
    CTO, Lipotype GmbH
  • Multi-diagnostic approaches for patient selection in immuno-oncology
    Cindy Spittle
    VP Scientific Affairs, ICON Laboratory Services
  • Keynote Presentation: The biomarker to companion diagnostic continuum: a road map for the delivery of precision medicine
    FEB 24, 2021 7:30 AM PST
    Steven M. Anderson, PhD
    Chief Scientific Officer, Covance Drug Development
  • FEB 24, 2021 9:00 AM PST
    Andrew Roche, PhD, Roger Hayes, PhD
    Andrew Roche, PhD
    Senior Director, Scientific Affairs, ICON Laboratory Se...
    Roger Hayes, PhD
    Vice President, Bioanalytical Services, ICON Laboratory...
  • FEB 24, 2021 3:00 PM PST
    Leif Schauser, PhD, Joseph Pearson, PhD
    Sponsored By: QIAGEN
    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    Joseph Pearson, PhD
    Global Product Manger
  • FEB 24, 2021 3:00 PM PST
    Leif Schauser, PhD, Joseph Pearson, PhD
    Sponsored By: QIAGEN
    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    Joseph Pearson, PhD
    Global Product Manger
Speakers

  • Yamina A. Berchiche, PhD
    Founder, Dr. GPCR
    Biography

      Dr. Yamina A. Berchiche is the founder of Dr. GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors (GPCRs), that control virtually everything in the body, as drug targets. The mission of Dr. GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the field and provide exposure to scientists through the Dr. GPCR podcast. Dr. Berchiche obtained her Master's and Ph.D. in Biochemistry at the University of Montreal in Canada before training at The Rockefeller University in New York and the National Institutes of Health in Bethesda, Maryland. She developed expertise over the past 2 decades studying structure/function relationships of GPCRs using live cell bioluminescence resonance energy transfer (BRET). Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the body.

    • Don Alexander, CPC, CFP®
      President and Managing Director, GeneCoda
      Biography

        As a recruiter with over 20 years of professional and executive search industry experience, Don Alexander has spent more than 16 years focusing exclusively on talent acquisition and recruiting, nationwide, for seasoned professionals in the Life Sciences sector (Biotechnology, Pharmaceutical, Medical Device, Diagnostics and supporting Services and Tools). He has successfully completed hundreds of recruitment projects that involved senior level individual contributors through C level executives, with particular emphasis on sales, business development, marketing, product development, project management and pre-clinical R&D. Throughout his recruiting career, Don has finished in the top 10% and consistently finished in the top 25% of his peer group, as ranked by revenues. An enabler of relationships that have resulted in quantifiable goodwill for his constituency, he is recognized by clients, candidates, and colleagues for routinely creating value through a robust network and deep industry perspective. Prior to working at the intersection of Life Sciences and recruiting, Don spent the first years of his career in the financial sector managing millions of dollars in assets. This uncommon background, and breadth of business knowledge, enables Don to understand the recruitment process in a much larger context than just the placement of a single individual. It's about a business investing in its growth—and mitigating risks. In addition to actively volunteering to help others, he enjoys rooting for NCSU, reading, investing, traveling and playing guitar. He even played “Stairway to Heaven” in his high school band but that was a while ago.

      • Keith Bowers, PhD
        Senior Business Development Manager, OracleBio
        Biography

          Keith has worked in the Pharmaceutical industry for over 25 years, with experience in large Pharma, Biotech and the contract services sector. He has held positions of both scientific, project and people leadership, with experience across the drug development pipeline, from HTS to through to early clinical development support, including biomarker and translational science studies.

        • Sherry A. Dunbar, PhD, MBA
          Senior Director, Global Scientific Affairs
          Biography
            Dr. Dunbar received a B.S. degree in Microbiology and Immunology, and a MBA from the University of Maryland. She completed a Ph.D. in Medical Microbiology and Immunology from the University of South Alabama and a post-doctoral fellowship in Clinical and Public Health Microbiology at Baylor College of Medicine. She was then the clinical laboratory director at Virus Reference Laboratory in Houston, Texas. Dr. Dunbar joined Luminex as a Senior Scientist in 1999 and served as Senior Director of the Biology Research and Development group for eight years. This group developed assay protocols, techniques, and helped to determine the best practices for xMAP Technology. During this time, the laboratory developed more than one hundred multiplexed assay panels for proteins, nucleic acids and other biomolecules. Currently, Dr. Dunbar is the Senior Director of Global Scientific Affairs for Luminex. She has more than forty publications in the peer-reviewed literature and numerous abstracts presented at scientific conferences.
          • Jason Frazier
            Director of Scientific Operations, Presage Biosciences
            Biography

              Jason Frazier is the Director of Scientific Operations for Presage Biosciences, a Phase 0 clinical research organization.  He oversees Presage's testing lab and preclinical research lab operations in support of partner sponsored clinical and preclinical research.  He has spent the past ten years at Presage working to develop and expand the novel CIVO micro-dosing platform as well as implementing new assay technologies to assess biological responses in CIVO micro-dosed patient tumor studies.  Prior to joining Presage, he worked as a scientist at Targeted Growth and at Rosetta Inpharmatics/Merck Research Laboratories working on development of a lentiviral shRNA High Throughput Screening platform for Merck biomarker and target discovery efforts.

            • Annette Gilchrist, PhD
              Associate-Professor, Pharmaceutical Sciences, Midwestern University
              Biography
                An Associate Professor with Midwestern University, and adjunct faculty member at Northwestern University Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she was with Cue Biotech and Caden Biosciences, companies she co-founded that focused on identifying modulators of G protein-coupled receptors (GPCRs) utilizing novel approaches (US Patent Numbers 6,559,128; 7,208,279; and 7,294,472). Her current research is on allosteric and functionally selective modulators of GPCRs with her primary receptors of interest being the chemokine receptor CCR1 and the recently deorphanized FFAR2. She is an International Editor for the British Journal of Clinical Pharmacology and recently served as a guest co-editor for a Frontiers in Endocrinology Bone Research themed issue on "Chemokines and Bone".
              • Roger Hayes, PhD
                Vice President, Bioanalytical Services, ICON Laboratory Services
                Biography

                  Roger Hayes, PhD, is the Vice President of Bioanalytical Services with the ICON Laboratory Services group. Roger joined ICON (Dublin, Ireland) in December of 2018. In this role, Roger holds overall management responsibility for our bioanalytical laboratory in Whitesboro, New York supporting pharmacokinetic, pharmacodynamic, immunogenicity and biomarker assays for large- and small-molecule drug development. Dr Hayes has held numerous leadership positions in the global life sciences industry and academia, leading teams in the development of state-of-the-art bioanalytical and analytical techniques, including mass spectrometry, chromatography, immunology and automation in bringing medical and chemical products to market. For nearly two decades, he led strategic and research initiatives for large pharmaceutical companies that included both GLP and non-GLP preclinical studies as well as clinical trials.

                • Joseph J. Senn, PhD, DABT
                  Vice President, Nonclinical Sciences, Moderna
                  Biography

                    As VP of Nonclinical Sciences, Joseph Senn oversees all nonclinical development, Toxicology, pathology, DMPK, Clinical pharmacology and in vivo pharmacology, across Moderna and its ventures. Prior to joining Moderna, Dr. Senn was director and site head for Drug Safety Evaluation and therapeutic area lead for immunology at Takeda Pharmaceuticals.  . Dr. Senn is a board certified toxicologist who received his PhD in Pharmacology and Physiology from the University of Rochester School of Medicine and Dentistry.  He has held joint faculty positions at the Medical University of South Carolina as assistant professor of pediatrics and pharmacology prior to entering industry.  In industry, his focus has been on immunotoxicology, investigative, discovery and development toxicology.  Over his time in industry he has supported the development of programs in a wide range of therapeutic areas including immune modulators, oncology, neurology, inflammatory and infectious diseases.  He has led multiple regulatory filings for modalities ranging from small molecules, biologics and antibody drug conjugates and most recently modified messenger RNA.

                  • Josh Jenkins, MS
                    Sales Development Manager, Licensed Technologies Group, Luminex Corporation
                  • Juan José Fung, PhD
                    Principal Scientist, GPCR Therapeutics
                    Biography

                      Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc, a drug discovery company focused on targeting GPCR heteromers in cancer, located in Seoul, Korea. Dr. Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Brian Kobilka, studying dimerization of GPCRs. Dr. Fung continued his Postdoctoral training in Dr. Kobilka's lab contributing to the elucidation of high-resolution structures of GPCRs. Dr. Fung has spent significant time in industry studying membrane proteins, antibodies and HTS methods for drug discovery. His current work is mainly focused on assay development to bridge the gap between in vitro and in vivo GPCR pharmacology.

                    • Aarti Kawatkar
                      Sr. Scientist, Chemical Biology and Proteomics group, AstraZeneca
                      Biography

                        Aarti Kawatkar was trained as an organic chemist, obtaining her M.S. from the University of Georgia at Athens in 2005 with Prof. Geert-Jan Boons. She started her industrial career as a medicinal chemist at Vertex, and in 2008, she moved to AstraZeneca as a lead chemist in both oncology and the fragment based lead generation group contributing to the discovery of several clinical candidates. In 2013 she joined AstraZeneca's newly created Chemical Biology group, focusing on small molecule target deconvolution and target engagement, supporting multiple drug discovery projects at different stages from hit identification to lead optimization to clinical candidates selection. In the chemical biology group, Aarti has championed the application of the CEllular Thermal Shift Assay (CETSA) and in-cell Chemoproteomics to measure cellular target engagement and target validation for multipass transmembrane protein receptors. Aarti's efforts in studying difficult targets was recognized in 2017 with AstraZeneca's Breakthrough Scientist of the Year award for "Innovative techniques for profiling target engagement and selectivity for multipass transmembarne proteins".  Again in 2020, she was awarded for finding the target of a small molecule modulator of inflammation.

                      • Mark Kiel, MD, PhD
                        Co-Founder and Chief Science Officer, Genomenon
                        Biography

                          Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon - an A.I.-driven life science company addressing the challenge of connecting pharma researchers with evidence in the literature to help diagnose and treat patients with genetic diseases and cancer.

                        • Dr. Christian Klose
                          CTO, Lipotype GmbH
                          Biography

                            After receiving his PhD on membrane biology and biophysics, Dr. Christian Klose did a post-doc on mass spectrometry-based lipidomics. In his role as CTO, Christian focusses on the development of novel shotgun lipidomics technology and is responsible for product development and regulatory affairs.

                          • Jie Jack Li, PhD
                            Vice President, Discovery Chemistry at ChemPartner
                          • Steven M. Anderson, PhD
                            Chief Scientific Officer, Covance Drug Development
                            Biography

                              Steven Anderson is senior vice president and chief scientific officer for Covance Drug Development. He has worked for LabCorp for 30 years and has held a variety of positions, including director of operations for ViroMed Laboratories, director of operations for Monogram Biosciences, director of operations for the Center for Molecular Biology and Pathology, director of operations for Integrated Oncology and Integrated Genetics, national director of research and development, and global head of LabCorp Clinical Trials.  His research interests include Molecular Pathology and Oncology based biomarkers, and that work has resulted in the development and validation of multiple companion diagnostics and pharmacogenomic assays in clinical use today. He holds a doctorate in genetics from Iowa State University and was an American Cancer Society postdoctoral fellow at the Waksman Institute of Microbiology at Rutgers University.

                            • Josh Mahlios, PhD
                              Senior Marketing Product Manager, Miltenyi Biotec
                              Biography
                                Josh Mahlios is a Senior Marketing Product Manager at Miltenyi Biotec, responsible for cell separation technologies and immunology focused applications. In these roles, he drives the awareness and adoption of the reagents and instrumentation specifically developed for both basic and translational researchers investigating the immune system. Prior to joining Miltenyi Biotec in 2016, Josh was a postdoctoral scholar at Stanford University.
                              • Dave Mason, PhD
                                Technical Sales Specialist, Visiopharm
                                Biography

                                  Dave Mason is a Technical Specialist in Image Analysis supporting Visiopharm's UK and European Sales team. Trained as a Cell Biologist and Microbiologist he has spent over a decade in Academia specializing in Light Microscopy and Digital Image Analysis.

                                • Rouba Najjar, MBA
                                  Senior Product Manager, GenScript
                                  Biography

                                    Rouba Najjar is has worked in the Biotech industry for 10+ years. Currently responsible for GenScript's Gene Editing and Molecular Biology products, acting as the voice of customer. Before joining GenScript, Rouba held various roles with a focus on automated solutions including Product Manager at Hamilton Robotics and Automation Team Lead at Baylor College of Medicine.

                                  • Reid Olsen, PhD, Pharmacology, Head of GPCR Pharmacology
                                    Exscientia Ltd
                                    Biography

                                      Dr. Reid Olsen is the head of GPCR Pharmacology at Exscientia Ltd. (Exscientia.ai), an AI-driven drug discovery biotechnology in Oxford, England. Dr. Olsen received his Ph.D. from the University of North Carolina at Chapel Hill under the mentorship of Dr. Bryan Roth. Dr. Olsen's research spans multiple domains within pharmacology and neurobiology, but has been primarily focused on the development of biological tools for the study of GPCR signaling in vitro and in vivo.

                                    • Joseph Pearson, PhD
                                      Global Product Manger
                                      Biography

                                        Joseph Pearson is the Global Product Manager for QIAGEN OmicSoft products, which enable scientists to harness the breadth of deeply-curated ‘omics data to accelerate biomarker and target discovery research. Prior to joining QIAGEN, he earned his Ph.D at the University of California, San Diego, where he used computational and experimental approaches to decipher cis-regulatory codes controlling epidermal wound responses in Drosophila. During his post-doctoral research at University of North Carolina, Chapel Hill, Dr. Pearson continued to explore the diversity of cis-regulatory mechanisms, using genomics, transgenics, microscopy, and bioinformatics to isolate and dissect enhancers responsible for early nervous system gene expression.

                                      • Professor Kevin Pfleger
                                        Director Biomedical Innovation, The University of Western Australia
                                        Biography

                                          Professor Pfleger is Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Western Australian Life Sciences Innovation Hub. He is also Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix and co-founder of RAGE Biotech. Professor Pfleger currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group. Professor Pfleger has developed extensive expertise in profiling receptor binding and function at the molecular and cellular levels over the last 20 years, particularly involving G protein-coupled receptors (GPCRs). He also has globally-recognised expertise in the bioluminescence resonance energy transfer (BRET) technology, including his patented Receptor-Heteromer Investigation Technology (Receptor-HIT) for studying heteromers.

                                        • Marsha Pierce, PhD
                                          Assistant Professor, Department of Pharmacology, Midwestern University
                                          Biography

                                            Dr. Marsha Pierce is an assistant professor at Midwestern University where she studies the role of oxytocin analogs in cellular signaling and neuronal morphology and marine natural products in neuroscience drug development. Dr. Pierce received her BS in biology and MS and PhD in biomedical sciences at Creighton University. Her postdoctoral research examined the role of natural variation in oxytocin and vasopressin ligands and receptors on pharmacological signaling profiles under the mentorship of Thomas Murray at Creighton University.

                                          • Andrew Roche, PhD
                                            Senior Director, Scientific Affairs, ICON Laboratory Services
                                            Biography

                                              Dr Roche has a Degree and PhD from Trinity College Dublin and has since accumulated 20 years experience within the clinical trials industry with particular focus on the intricacies of biomarkers, associated laboratory methods and their ability to facilitate an efficient and accurate assessment of the clinical safety and efficacy of therapeutics moving through clinical trials.

                                            • Cynthia Rohde, PhD, DABT
                                              Associate Research Fellow, Drug Safety Research and Development, Pfizer, Inc.
                                              Biography

                                                Cynthia Rohde is currently an Associate Research Fellow in the Drug Safety Research and Development department at Pfizer, Inc. She been a drug development research scientist in the pharmaceutical industry for over 13 years with experience across various therapeutic areas and modalities, but is current focusing on Oncology therapies and Vaccines. Cynthia received her PhD in Biochemistry from the University of Wisconsin-Madison and is a Diplomate of the American Board of Toxicology.

                                              • Nishant Saxena, PhD
                                                Product Manager, GenScript
                                                Biography

                                                  Nishant Saxena is a product manager for protein and antibody purification portfolio in GenScript USA Inc. He has multiple years of lab experience in protein and antibody purification with a special focus on monoclonal antibody production using hybridoma technology. In this talk, he will present a newly designed automated protein and antibody purification platform, developed by GenScript, that is based on magnetic beads technology. Nishant holds a Ph.D. degree from Tsukuba University in Japan with double masters in biotechnology and nanotechnology.

                                                • Leif Schauser, PhD
                                                  Director, Global Product Management, QIAGEN
                                                  Biography
                                                    Leif Schauser holds a Ph.D. in Plant Molecular Genetics from Aarhus University, Denmark. He did his postdoctoral training in Norwich, UK, before working as a professor in Bioinformatics at Aarhus University. In 2013 Leif joined CLC bio, just before its acquisition by QIAGEN.
                                                  • Cindy Spittle
                                                    VP Scientific Affairs, ICON Laboratory Services
                                                    Biography

                                                      Cindy Spittle is the Vice President of Scientific Affairs within the ICON Laboratory Services group. Dr. Spittle has over 30 years of experience in translational and clinical oncology biomarker research, diagnostic assay development and biomarker strategy for clinical drug development. She provides strategic scientific leadership related to the evaluation and implementation of new technologies and laboratory testing services.

                                                    • Sarah Warren, PhD
                                                      Sr Director of Translational Science, NanoString Technologies
                                                      Biography

                                                        Sarah Warren is the Senior Director of Translational Science at NanoString Technologies where she leverages multiplexed, molecular profiling technologies to address key research areas in oncology, immunology, and beyond. Her role enables her to work with academics, biopharmas, and clinicians to identify unmet needs in translational research and create novel products for transcriptional and proteomic profiling. She is also active in the immuno-oncology research community to promote the science and application of cancer immunotherapy to improve patient outcomes. Prior to joining NanoString, she was a founder and director of research at Oncofactor Corp., a Seattle biotech startup focused on developing therapeutics which targeted novel immune checkpoints. She has a PhD in immunology from the University of Washington and performed her graduate work at the Institute for Systems Biology.

                                                      • Ajay Yekkirala, PhD
                                                        Co-Founder & CSO, Blue Therapeutics
                                                        Biography

                                                          Ajay Yekkirala is a co-founder of Blue Therapeutics, a platform company focused on utilizing the power of receptor-interactomicsTM to develop novel therapies.  He is the co-inventor of Blue's core technology and has over 15 years of experience in GPCR and ion channel drug discovery and development. Ajay completed his doctoral studies with ACS hall of fame chemist, Dr. Philip Portoghese, at the University of Minnesota and postdoctoral training under renowned pain neurobiologist Clifford Woolf at Harvard. He has authored several papers published in high-impact, peer-reviewed journals, including book chapters and invited reviews. He is also a recipient of the Bacaner Research Award from the Minnesota Medical Foundation.

                                                        • Vevian Zhang
                                                          Product Manager, GenScript
                                                          Biography

                                                            Currently responsible at GenScript for cell biology products development and management. Before joining GenScript, I had 10+ years' research experience in disease mechanism and drug development in a wide range of fields including leukemia, and mechanism research of metabolism and reproductive endocrinology.

                                                          Sponsored by

                                                          For information on becoming a sponsor or exhibitor, please click here.


                                                          C.E. Credits

                                                          The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                          Committee

                                                          To download the Program Committee brochure here.


                                                          • Annette Gilchrist

                                                            An Associate Professor with Midwestern University, and adjunct faculty member at Northwestern University Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she ...

                                                            See more See less
                                                          • Matthew Flegal

                                                            Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

                                                            See more See less
                                                          • Martin Shaw

                                                            Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...

                                                            See more See less
                                                          • Matthew Shipton

                                                            Leading Novabiosis' primary cell business, Matthew brings to the Company a skill for implementing sales-driven business strategies, an extensive track record of meeting and surpassing targeted sales objectives, and a passion for translating customer needs into solutions that ...

                                                            See more See less
                                                          Help

                                                          General Labroots Questions

                                                          email support@labroots.com  

                                                          Virtual Events and Webinars

                                                          Supported Configurations

                                                          • Operating System Internet Explorer Firefox Chrome Safari
                                                            Vista IE8+ FF10+ Chrome15+
                                                            Windows 7 IE8+ FF10+ Chrome15+
                                                            Windows 8 IE10 FF10+ Chrome15+
                                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                          • Cookie settings: session cookies enabled
                                                          • Browser configuration must have JavaScript enabled
                                                          • Adobe Flash player 10.2 or later

                                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                          Internet Connection

                                                          • A minimum of 100Kbps is recommended for audio-only events
                                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                                          Computer Equipment

                                                          • Screen Resolution: Minimum 1024x768
                                                          • Video Card: 65,000 colors minimum
                                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                                          • Audio Card: 16-bit minimum
                                                          • RAM: 512MB of free RAM

                                                          Firewall Protocol

                                                          • HTTP on port 80 or HTTPS on port 443
                                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                          Work-At-Home Attendees

                                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                          For A Seamless Experience

                                                          When using a mobile device, FREE Mobile Apps are available:

                                                          - For viewing Webinars:

                                                          - For viewing Virtual Events

                                                          Attendee Guide

                                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                          Virtual Event and Webinar Support:

                                                          Continuing Education (CME/CE) Support

                                                          Demographics

                                                          Specialty

                                                          Research And Development

                                                          Research

                                                          Drug Development

                                                          Cancer

                                                          Disease

                                                          Molecular Biology

                                                          Molecular Genetics

                                                          Cell

                                                          Immunology

                                                          Health

                                                          Clinical Medicine

                                                          Gene

                                                          Cancer Research

                                                          Cell Biology

                                                          Biotechnology

                                                          Geography

                                                          North America40%

                                                          Asia27%

                                                          Europe21%

                                                          Africa4%

                                                          South America3%

                                                          Oceania1%

                                                          Registration Source

                                                          Website Visitors52%

                                                          Labroots Registration (Also interested in)18%

                                                          WAVE Newsletter Promotion11%

                                                          Website Banners7%

                                                          Email Promotions7%

                                                          Trending Newsletter Promotion1%

                                                          Social Media Promotions1%

                                                          Client/Sponsor Promotions1%

                                                          Other1%

                                                          Job Title

                                                          Student23%

                                                          Research Scientist12%

                                                          Medical Laboratory Technician12%

                                                          Educator/Faculty9%

                                                          Executive7%

                                                          Facility/Department Manager7%

                                                          Scientist6%

                                                          Clinical Laboratory Scientist5%

                                                          Medical Doctor/Specialist4%

                                                          Lab Management3%

                                                          Biologist3%

                                                          Chemist2%

                                                          Post Doc2%

                                                          Veterinarian1%

                                                          Microbiologist1%

                                                          Marketing/Sales1%

                                                          Other1%

                                                          Organization

                                                          Academic Institution32%

                                                          Hospital9%

                                                          Clinical Laboratory8%

                                                          Biotech Company7%

                                                          Research Institute5%

                                                          Pharmaceutical Company4%

                                                          Government4%

                                                          Life Science Company3%

                                                          Contract Research Organization (Cro)2%

                                                          Medical School2%

                                                          Government/public2%

                                                          General Laboratory1%

                                                          Medical Center1%

                                                          Diagnostic Company1%

                                                          Other4%

                                                          Loading Comments...
                                                          Show Resources
                                                          Attendees
                                                          • See more